Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Zoledronic Acid to Bone Fusion and Bone Metabolism of Patients With Lumbar Degenerative Disease After Lumbar Interbody Fusion

NCT01310465 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT01310465
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01310465 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Zoledronic Acid to Bone Fusion and Bone Metabolism of Patients With Lumbar Degenerative Disease After Lumbar Interbody Fusion
Lead sponsor
Fudan University
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2011
Completion date
April 30, 2012
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone mineral density, bone turnover markers, image changes of lumbar fusion